• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Early mobilization after ICU mechanical ventilation does not improve survival

byNhat Hung (Benjamin) LamandKiera Liblik
November 22, 2022
in Chronic Disease, Emergency
Reading Time: 3 mins read
ICU chlorhexidine baths do not reduce rates of hospital-acquired infections
Share on FacebookShare on Twitter

1. Early mobilization of patients after mechanical ventilation in the intensive care unit (ICU) did not result in an improvement in the number of days alive and out of the hospital.

2. Early mobilization was associated with more adverse events than routine care.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Patients with a critical illness are often admitted to the ICU, many of whom develop weakness, resulting in increased mortality and prolonged recovery course. This weakness is especially marked in mechanically ventilated patients, due to muscle wasting and co-morbidities from their critical illnesses. Early mobilization has been suggested to mitigate the impact of ICU-associated weakness, although with limited evidence and regimen standards. The current study was a randomized controlled trial to evaluate the effects of early mobilization or usual care on the recovery of patients who underwent mechanical ventilation in the ICU. By 180 days, the number of days patients were alive and out of the hospital was not significantly different between the two groups. Both groups also showed similar outcomes in quality of life and function. Early mobilization was associated with a higher rate of adverse events. It was noted that patients receiving usual care had a higher level of baseline mobilization than in previous cohort studies. Nevertheless, these results demonstrated that early mechanical ventilation does not impact the number of days alive and out of the hospital compared to usual care.

Click here to read the study in NEJM

In-Depth [randomized controlled trial]: This study was a multicenter, randomized controlled trial assessing the impact of early mobilization on patients who underwent mechanical ventilation in the ICU. Adult patients were eligible if they were expected to receive mechanical ventilation after randomization and were stable enough for mobilization. Exclusion criteria included rest-in-bed orders, dependency in activities of daily living prior to admission, and brain or spinal injury. Overall, 750 adult patients were randomized 1:1 to receive either early mobilization (via sedation minimization and daily physiotherapy) or usual care (baseline mobilization provided in the ICU). The primary outcome was the number of days patients were alive and out of the hospital at 180 days following randomization. The early-mobilization group had significantly more mobilization time daily than the usual-care group, and patients receiving early mobilization were able to stand earlier than those receiving usual care. The median number of days alive and out of the hospital was 143 (interquartile range [IQR], 21 to 161) in the early-mobilization group and 145 days (IQR, 51 to 164) in the usual-care group (absolute difference, -2.0 days; 95% Confidence Interval [CI], -10 to 6; p=0.62). The mortality rate was 22.5% for the early-mobilization group and 19.5% for the usual-care group (odds ratio, 1.15; 95% CI, 0.81 to 1.65). Notably, adverse events attributable to mobilization, such as arrhythmias, blood pressure alteration, and desaturation, were more prevalent in the early-mobilization group (9.2%) than in the usual-care group (4.1%) (p=0.005). Although the level of mobilization given under usual care was higher than in cohort studies, this was consistent with international guidelines and other clinical trials. These results showed that early mobilization did not impact the number of days alive and out of the hospital among patients receiving mechanical ventilation in the ICU.

RELATED REPORTS

Borderline-low hemoglobin levels linked to increased mortality

The mortality in-hospital for patients undergoing elective catheter ablation for atrial fibrillation is low

Lower levels of education and place of birth were associated with non-admission to the intensive care unit in Sweden during COVID-19 pandemic

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: chronic diseaseearly mobilizationemergencyemergency medicineICUICU survivalintensive care unitmobilizationmortalitysurvival
Previous Post

Ceftriaxone use is not associated with increased free bilirubin in term neonates with sepsis

Next Post

#VisualAbstract: Catheter cryoballoon ablation is superior in rhythm control for paroxysmal atrial fibrillation

RelatedReports

Cardiology

Borderline-low hemoglobin levels linked to increased mortality

September 14, 2026
Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source
Cardiology

The mortality in-hospital for patients undergoing elective catheter ablation for atrial fibrillation is low

September 4, 2026
Novel coronavirus identified from patients with pneumonia in Wuhan, China
Emergency

Lower levels of education and place of birth were associated with non-admission to the intensive care unit in Sweden during COVID-19 pandemic

September 1, 2026
“Housing First” linked to housing stability for homeless youth with mental illness
Public Health

Mortality in the post-housing period is high among homeless people in Ottawa, Canada

August 31, 2026
Next Post
#VisualAbstract: Catheter cryoballoon ablation is superior in rhythm control for paroxysmal atrial fibrillation

#VisualAbstract: Catheter cryoballoon ablation is superior in rhythm control for paroxysmal atrial fibrillation

FDA-approved weight loss medications associated with weight loss at one year

Very low-fat diet may be associated with increased glaucoma risk

Admission may not be needed following sleep apnea surgery

Accuracy and clinical utility of obstructive sleep apnea screening tools uncertain in primary care settings – US Preventive Services Task Force

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • First messenger RNA influenza vaccine outperforms standard-dose vaccination
  • Few interventions improve posthospitalization follow-up for alcohol use disorder
  • Borderline-low hemoglobin levels linked to increased mortality
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.